Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Interest Expenses (2016 - 2025)

AtriCure (ATRC) has disclosed Interest Expenses for 16 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 3.65% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.9 million, a 8.26% decrease, with the full-year FY2025 number at $5.9 million, down 8.26% from a year prior.
  • Interest Expenses was $1.5 million for Q4 2025 at AtriCure, up from $1.5 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.8 million in Q4 2023 to a low of $1.0 million in Q1 2022.
  • A 5-year average of $1.5 million and a median of $1.5 million in 2025 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: soared 63.6% in 2023, then fell 19.3% in 2024.
  • AtriCure's Interest Expenses stood at $1.1 million in 2021, then surged by 44.14% to $1.6 million in 2022, then grew by 15.18% to $1.8 million in 2023, then dropped by 19.3% to $1.5 million in 2024, then increased by 3.65% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Interest Expenses are $1.5 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025).